Cargando…
SL-2 Breast cancer treatment system
Surgery under general anesthesia for breast cancer was performed for the first time in Japan. Hormone therapy (bilateral ovariectomy, selective estrogen receptor modulator, LHRH analog, aromatase inhibitor, selective estrogen receptor down-regulator) has been developed for more than 120 years. Radia...
Autor principal: | Toi, Masakazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699125/ http://dx.doi.org/10.1093/noajnl/vdaa143.001 |
Ejemplares similares
-
SL-1 Activity on Nationwide Cancer Genome Screening Project for Advanced Solid Tumors; SCRUM-Japan GI-/MONSTAR-SCREEN
por: Yoshino, Takayuki
Publicado: (2020) -
OTHR-13. IMPACT the brain: improving metastatic breast cancer patient access to coordinated treatment
por: Grogan, Nicole, et al.
Publicado: (2021) -
BSCI-17. Targeting SIRPα as a therapeutic strategy for the treatment of breast cancer brain metastasis
por: Stirling, Elizabeth R, et al.
Publicado: (2021) -
74. EFFICACY OF HER2-TARGETED THERAPY IN HER2-POSITIVE BREAST CANCER BRAIN METASTASES: A NATIONAL ANALYSIS
por: Hulsbergen, Alexander, et al.
Publicado: (2020) -
34. TARGETED THERAPY FOR HER2-POSITIVE BREAST CANCER BRAIN METASTASES: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Erickson, Anders, et al.
Publicado: (2020)